CurrProblPediatrAdolescHealthCare. 2020May10;100785.doi:10.1016/j.cppeds.2020.100785. Online ahead of print.

Kelly Sandberg ¹, Elizabeth Yarger ², Shehzad Saeed ³

Author information

¹Department of Pediatric Gastroenterology, Dayton Children's Hospital, United States; Boonshoft School of Medicine, Wright State University, Dayton, OH, United States. Electronic address: sandbergk@childrensdayton.org.

²Department of Pediatric Gastroenterology, Dayton Children's Hospital, United States.

³Department of Pediatric Gastroenterology, Dayton Children's Hospital, United States; Boonshoft School of Medicine, Wright State University, Dayton, OH, United States.

Abstract

Worldwide incidence of inflammatory bowel disease (IBD) is stable in developed countries, but rising in developing countries. Presenting symptoms of IBD can be highly variable. New imaging modalities, a greater armamentarium of therapeutic options, and a greater understanding of complication risks have changed the diagnosis and management of pediatric inflammatory bowel diseases. Effective teamwork among those who care for pediatric patients with IBD minimizes complications and maximizes desired outcomes.